US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aspire Biopharma Holdings Inc.

0.4871

-0.0205-4.04%

Post-market: 0.4830-0.0041-0.84%19:07 EDT

Volume:80.57K

Turnover:39.92K

Market Cap:23.82M

PE:-333.17

High:0.5209

Open:0.5180

Low:0.4755

Close:0.5076

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement

ACCESS Newswire

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

ACCESS Newswire

Sector Update: Health Care Stocks Mixed in Afternoon Trading

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ASBP"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","market":"US","secType":"STK","nameCN":"Aspire Biopharma Holdings Inc.","latestPrice":0.4871,"timestamp":1745611200000,"preClose":0.5076,"halted":0,"volume":80566,"hourTrading":{"tag":"盘后","latestPrice":0.483,"preClose":0.4871,"latestTime":"19:07 EDT","volume":15190,"amount":7005.225,"timestamp":1745622444345},"delay":0,"floatShares":31062729,"shares":48901000,"eps":-0.001462,"marketStatus":"Market Closed","change":-0.0205,"latestTime":"04-25 16:00:00 EDT","open":0.518,"high":0.5209,"low":0.4755,"amount":39920.8074904,"amplitude":0.089441,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.001462,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.5076,"preHourTrading":{"tag":"盘前","latestPrice":0.5076,"preClose":0.5076,"latestTime":"09:02 EDT","volume":6,"amount":3.0981001800000003,"timestamp":1745586127845},"postHourTrading":{"tag":"盘后","latestPrice":0.483,"preClose":0.4871,"latestTime":"19:07 EDT","volume":15190,"amount":7005.225,"timestamp":1745622444345},"volumeRatio":1.0661556059502946},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","floatShares":31062729,"roa":"--","roe":"--","lyrEps":-0.00081,"volumeRatio":1.0661556059502946,"shares":48901000,"dividePrice":0,"high":0.5209,"amplitude":0.089441,"preClose":0.5076,"low":0.4755,"week52Low":0.4011,"pbRate":"-29.72","week52High":15.8,"institutionHeld":0,"latestPrice":0.4871,"eps":-0.001462,"divideRate":0,"volume":80566,"delay":0,"ttmEps":-0.001462,"open":0.518,"prevYearClose":11.5,"prevWeekClose":0.568,"prevMonthClose":0.5826,"prevQuarterClose":0.5826,"fiveDayClose":0.568,"twentyDayClose":0.66,"sixtyDayClose":11.52},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ASBP\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASBP\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527549911","title":"Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream","url":"https://stock-news.laohu8.com/highlight/detail?id=2527549911","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527549911?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:00","pubTimestamp":1744714800,"startTime":"0","endTime":"0","summary":"MIAMI, April 15, 2025  -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 81th Emerging Growth Conference on April 16 & 17, 2025.The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/presenting-emerging-growth-conference-81-110000154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNZI","CUAUF","OPWEF","PSQ","QLD","USEG","NVA.AU","PSQH","BK4077","TSYW.SI","USJW.SI","XXII","TQQQ","BK4023","BK4139","GOVX","NVA","BK4583","USAW.SI","UURAF","BK4137","BK4124","BK4168","ASBP","NQmain","NVIW.SI","CLNN","EVFM","BIXT","BENF","URG","MNQmain","BK4017","OMEX","BK4162","BK4075","BK4196","QID","SBC","CIA","BK4007","NVAWW","ELRRF",".IXIC","SEVCF","BK4584","BK4135","HGRAF","SQQQ","BK4213"],"gpt_icon":1},{"id":"2526416661","title":"Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement","url":"https://stock-news.laohu8.com/highlight/detail?id=2526416661","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526416661?lang=en_us&edition=fundamental","pubTime":"2025-04-11 20:30","pubTimestamp":1744374600,"startTime":"0","endTime":"0","summary":"Plans to conduct consumer and safety testing during second quarter 2025. Desert Stream Inc.,a leading private label manufacturer in the health and wellness industry, performing initial production. Single dose pre-workout supplement expected to be available in at least three flavors and launch in specialty retailers of nutritional products in 2025. HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / April 11, 2025 / Aspire Biopharma Holdings, Inc.  , a developer of a multi-faceted patent-pending disruptive drug and supplement delivery technology, announced today it has begun initial production of its single dose pre workout supplement utilizing Aspire's patent-pending and proprietary sublingual delivery technology. The clinically dosed pre-workout formula is expected to be conveniently packaged in a single serving sachet for easy on-the-go use. The Company expects to begin consumer and safety testing of this supplement product during the second quarter of 2025.Aspire's initial pre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aspire-biopharma-holdings-inc-commences-123000840.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","ASBP","ASBPW"],"gpt_icon":0},{"id":"2526336261","title":"Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2526336261","media":"ACCESS Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526336261?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:30","pubTimestamp":1744201800,"startTime":"0","endTime":"0","summary":"Trial designed to evaluate safety, pharmacokinetics and pharmacodynamics, of Aspire's sublingual aspirin product. Aspire anticipates releasing initial clinical data from trial at the end of the second quarter. Aspire intends to request \"fast track\" approval on FDA application for its high-dose aspirin product. HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Aspire Biopharma Holdings, Inc.  , a developer of a multi-faceted patent-pending drug delivery technology, today announced initiation of its Phase 1 single- center clinical study of its lead therapeutic candidate, an oral transmucosal fast-acting high-dose aspirin formulation.Phase 1 Study DesignThe objectives of this Phase 1 single dose clinical study are to evaluate the safety, pharmacokinetics and pharmacodynamics of Aspire's sublingual aspirin powder when administered orally in healthy adult volunteers. The Phase 1 clinical trial, which is being conducted in the United States, will compare the pharmacokinetic an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aspire-biopharma-holdings-inc-announces-123000062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","IE00BYQQ9H92.USD","IE00BFXG0V08.USD","ASBP","BK4007","IE00B5TLWC47.USD","BK4588","FAST","BK4104","ASA","BK4567","ASBPW"],"gpt_icon":0},{"id":"2521646700","title":"Sector Update: Health Care Stocks Mixed in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2521646700","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521646700?lang=en_us&edition=fundamental","pubTime":"2025-03-21 02:02","pubTimestamp":1742493728,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed Thursday afternoon, with the NYSE Health Care Index rising 0.3% and the Health Care Select Sector SPDR Fund  fractionally lower.The iShares Biotechnology ETF  fell 1.1%.In corporate news, Aspire Biopharma  shares rose 2.3% after it said Thursday its contract manufacturer Glatt Air Techniques produced the first clinical batch of pharmaceutical-grade oral mucosal form of aspirin with Aspire's formulation ahead of a bioavailability study expected to begin in April.OptiNose  shares surged 52% after the company overnight said it agreed to be acquired by Paratek Pharmaceuticals in a deal valued at up to $330 million.Aptevo Therapeutics  shares added 1.1% after it said Thursday that two additional acute myeloid leukemia patients achieved remission within 30 days of treatment in a trial evaluating mipletamig with standard therapy for patients unfit for intensive chemotherapy.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","OPTN","BK4007","XLV","BK4581","BK4588","BK4139","ASBP","APVO","BK4585"],"gpt_icon":1}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASBP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASBP","date":"2025-04-25","current":-36.428037,"percent":0.894737,"low":-107.647863,"twenty":-53.967461,"median":-44.487272,"eighty":-38.006872,"high":-28.792214,"avg":-46.609012,"sd":13.320157,"marketCap":23611087},"quantilePoints":[{"date":"2025-03-07","current":-61.718107,"twenty":-79.515888,"median":-61.718107,"eighty":-58.474317,"marketCap":40003023},{"date":"2025-03-14","current":-41.62384,"twenty":-63.871064,"median":-57.344015,"eighty":-54.828644,"marketCap":26978783},{"date":"2025-03-21","current":-49.388839,"twenty":-61.718107,"median":-55.259235,"eighty":-45.464716,"marketCap":32011722},{"date":"2025-03-28","current":-47.36506,"twenty":-59.766092,"median":-48.376949,"eighty":-45.613987,"marketCap":30699995},{"date":"2025-04-04","current":-38.75323,"twenty":-56.183571,"median":-46.367595,"eighty":-43.647619,"marketCap":25118177},{"date":"2025-04-11","current":-38.035578,"twenty":-55.34679,"median":-45.929755,"eighty":-40.946376,"marketCap":24653026},{"date":"2025-04-17","current":-39.57853,"twenty":-55.287942,"median":-45.474044,"eighty":-39.546954,"marketCap":25653101},{"date":"2025-04-25","current":-36.428037,"twenty":-53.967461,"median":-44.487272,"eighty":-38.006872,"marketCap":23611087}],"updateTime":1745775761647}}}